メインコンテンツにスキップ
ホーム / コンテンツ / イベント / 3rd Annual Gene Therapy
for Neurological Disorders

3rd Annual Gene Therapy
for Neurological Disorders

3rd Annual Gene Therapyfor Neurological Disorders
Presentation(s)

How Regulatory-ready Biosimulation Advances Pre-clinical and Clinical CNS Drug Development

Piet van der Graaf

|

SVP Quantitative Science Services

• Predict dose-response relationship between administered viral load and target protein expression • For Gene Therapy and Neurological Diseases, these tools increase confidence around dosing, immunogenicity, and special populations • QSP modeling using virtual patients/trials supported by global regulators

Powered by Translations.com GlobalLink OneLink Software